Molecular mechanisms of long noncoding RNAs and their role in disease pathogenesis

LncRNAs are long non-coding regulatory RNAs that are longer than 200 nucleotides. One of the major functions of lncRNAs is the regulation of specific gene expression at multiple steps including, recruitment and expression of basal transcription machinery, post-transcriptional modifications and epige...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget Vol. 9; no. 26; p. 18648
Main Authors: Hu, Guoku, Niu, Fang, Humburg, Bree A, Liao, Ke, Bendi, Sunil, Callen, Shannon, Fox, Howard S, Buch, Shilpa
Format: Journal Article
Language:English
Published: United States 06.04.2018
Subjects:
ISSN:1949-2553, 1949-2553
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract LncRNAs are long non-coding regulatory RNAs that are longer than 200 nucleotides. One of the major functions of lncRNAs is the regulation of specific gene expression at multiple steps including, recruitment and expression of basal transcription machinery, post-transcriptional modifications and epigenetics [1]. Emerging evidence suggests that lncRNAs also play a critical role in maintaining tissue homeostasis during physiological and pathological conditions, lipid homeostasis, as well as epithelial and smooth muscle cell homeostasis, a topic that has been elegantly reviewed [2-5]. While aberrant expression of lncRNAs has been implicated in several disease conditions, there is paucity of information about their contribution to the etiology of diseases [6]. Several studies have compared the expression of lncRNAs under normal and cancerous conditions and found differential expression of several lncRNAs, suggesting thereby an involvement of lncRNAs in disease processes [7, 8]. Furthermore, the ability of lncRNAs to influence epigenetic changes also underlies their role in disease pathogenesis since epigenetic regulation is known to play a critical role in many human diseases [1]. LncRNAs thus are not only involved in homeostatic functioning but also play a vital role in the progression of many diseases, thereby underscoring their potential as novel therapeutic targets for the alleviation of a variety of human disease conditions.
AbstractList LncRNAs are long non-coding regulatory RNAs that are longer than 200 nucleotides. One of the major functions of lncRNAs is the regulation of specific gene expression at multiple steps including, recruitment and expression of basal transcription machinery, post-transcriptional modifications and epigenetics [1]. Emerging evidence suggests that lncRNAs also play a critical role in maintaining tissue homeostasis during physiological and pathological conditions, lipid homeostasis, as well as epithelial and smooth muscle cell homeostasis, a topic that has been elegantly reviewed [2-5]. While aberrant expression of lncRNAs has been implicated in several disease conditions, there is paucity of information about their contribution to the etiology of diseases [6]. Several studies have compared the expression of lncRNAs under normal and cancerous conditions and found differential expression of several lncRNAs, suggesting thereby an involvement of lncRNAs in disease processes [7, 8]. Furthermore, the ability of lncRNAs to influence epigenetic changes also underlies their role in disease pathogenesis since epigenetic regulation is known to play a critical role in many human diseases [1]. LncRNAs thus are not only involved in homeostatic functioning but also play a vital role in the progression of many diseases, thereby underscoring their potential as novel therapeutic targets for the alleviation of a variety of human disease conditions.LncRNAs are long non-coding regulatory RNAs that are longer than 200 nucleotides. One of the major functions of lncRNAs is the regulation of specific gene expression at multiple steps including, recruitment and expression of basal transcription machinery, post-transcriptional modifications and epigenetics [1]. Emerging evidence suggests that lncRNAs also play a critical role in maintaining tissue homeostasis during physiological and pathological conditions, lipid homeostasis, as well as epithelial and smooth muscle cell homeostasis, a topic that has been elegantly reviewed [2-5]. While aberrant expression of lncRNAs has been implicated in several disease conditions, there is paucity of information about their contribution to the etiology of diseases [6]. Several studies have compared the expression of lncRNAs under normal and cancerous conditions and found differential expression of several lncRNAs, suggesting thereby an involvement of lncRNAs in disease processes [7, 8]. Furthermore, the ability of lncRNAs to influence epigenetic changes also underlies their role in disease pathogenesis since epigenetic regulation is known to play a critical role in many human diseases [1]. LncRNAs thus are not only involved in homeostatic functioning but also play a vital role in the progression of many diseases, thereby underscoring their potential as novel therapeutic targets for the alleviation of a variety of human disease conditions.
LncRNAs are long non-coding regulatory RNAs that are longer than 200 nucleotides. One of the major functions of lncRNAs is the regulation of specific gene expression at multiple steps including, recruitment and expression of basal transcription machinery, post-transcriptional modifications and epigenetics [1]. Emerging evidence suggests that lncRNAs also play a critical role in maintaining tissue homeostasis during physiological and pathological conditions, lipid homeostasis, as well as epithelial and smooth muscle cell homeostasis, a topic that has been elegantly reviewed [2-5]. While aberrant expression of lncRNAs has been implicated in several disease conditions, there is paucity of information about their contribution to the etiology of diseases [6]. Several studies have compared the expression of lncRNAs under normal and cancerous conditions and found differential expression of several lncRNAs, suggesting thereby an involvement of lncRNAs in disease processes [7, 8]. Furthermore, the ability of lncRNAs to influence epigenetic changes also underlies their role in disease pathogenesis since epigenetic regulation is known to play a critical role in many human diseases [1]. LncRNAs thus are not only involved in homeostatic functioning but also play a vital role in the progression of many diseases, thereby underscoring their potential as novel therapeutic targets for the alleviation of a variety of human disease conditions.
Author Niu, Fang
Liao, Ke
Callen, Shannon
Bendi, Sunil
Fox, Howard S
Buch, Shilpa
Humburg, Bree A
Hu, Guoku
Author_xml – sequence: 1
  givenname: Guoku
  surname: Hu
  fullname: Hu, Guoku
  organization: Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA
– sequence: 2
  givenname: Fang
  surname: Niu
  fullname: Niu, Fang
  organization: Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA
– sequence: 3
  givenname: Bree A
  surname: Humburg
  fullname: Humburg, Bree A
  organization: Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA
– sequence: 4
  givenname: Ke
  surname: Liao
  fullname: Liao, Ke
  organization: Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA
– sequence: 5
  givenname: Sunil
  surname: Bendi
  fullname: Bendi, Sunil
  organization: Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA
– sequence: 6
  givenname: Shannon
  surname: Callen
  fullname: Callen, Shannon
  organization: Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA
– sequence: 7
  givenname: Howard S
  surname: Fox
  fullname: Fox, Howard S
  organization: Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA
– sequence: 8
  givenname: Shilpa
  surname: Buch
  fullname: Buch, Shilpa
  organization: Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29719633$$D View this record in MEDLINE/PubMed
BookMark eNpNUDtPwzAYtFARLaU_gAV5ZEmxPztxPVYVL6mAVMEcOfHn1iixS5wM_HtaUSRuuRvuId0lGYUYkJBrzuZ8UQi4i6GOvem22M9BCqbOyIRrqTPIczH6p8dkltInOyCXagH6goxBK64LISZk8xIbrIfGdLTFemeCT22i0dEmhi0Nxw3rD2rzukzUBEv7HfqOdocU9YFan9AkpHvT7-IWAyafrsi5M03C2Ymn5OPh_n31lK3fHp9Xy3VWCy5VZpyUrEZhFhqcAS0dA255rZR10sjcOQkFVBWXR7DcVTrXUHCreFGxysKU3P727rv4NWDqy9anGpvGBIxDKoEJCVooxQ_Wm5N1qFq05b7zrem-y78f4AekzGN4
CitedBy_id crossref_primary_10_1007_s12035_023_03626_y
crossref_primary_10_3389_fgene_2019_00680
crossref_primary_10_1186_s12864_022_08805_0
crossref_primary_10_1016_j_cca_2022_12_010
crossref_primary_10_1007_s11033_025_10975_5
crossref_primary_10_1038_s41419_022_04717_9
crossref_primary_10_1111_jcmm_17014
crossref_primary_10_3390_genes16040420
crossref_primary_10_1038_s41598_023_37898_0
crossref_primary_10_4331_wjbc_v11_i2_62
crossref_primary_10_1097_MD_0000000000033075
crossref_primary_10_7554_eLife_81360
crossref_primary_10_1097_MD_0000000000027178
crossref_primary_10_1007_s12038_023_00349_z
crossref_primary_10_1016_j_lfs_2019_116731
crossref_primary_10_3390_biom10071044
crossref_primary_10_1016_j_chembiol_2021_03_003
crossref_primary_10_3390_cancers13122979
crossref_primary_10_1186_s12864_020_07055_2
crossref_primary_10_3892_mmr_2019_9906
crossref_primary_10_1016_j_jpsychires_2023_06_017
crossref_primary_10_1016_j_imlet_2020_08_001
crossref_primary_10_1016_j_cca_2025_120265
crossref_primary_10_1016_j_arr_2019_01_001
crossref_primary_10_3390_ijms20194898
crossref_primary_10_3389_fphar_2020_00641
crossref_primary_10_1089_cbr_2020_4429
crossref_primary_10_1016_j_jid_2021_09_031
crossref_primary_10_1155_2021_9978882
crossref_primary_10_1016_j_cca_2018_10_002
crossref_primary_10_1016_j_humgen_2025_201469
crossref_primary_10_1080_09674845_2019_1675847
crossref_primary_10_3389_fonc_2021_822745
crossref_primary_10_1038_s41598_020_80291_4
crossref_primary_10_3389_fgene_2020_628539
crossref_primary_10_1111_jcmm_14087
crossref_primary_10_3389_fgene_2023_1024444
crossref_primary_10_1016_j_arr_2024_102556
crossref_primary_10_1080_09168451_2019_1673695
crossref_primary_10_1515_hmbci_2023_0012
crossref_primary_10_1371_journal_pone_0258194
crossref_primary_10_3390_cells8091015
crossref_primary_10_3390_biom15091255
crossref_primary_10_1016_j_gene_2019_03_066
crossref_primary_10_3390_genes9090437
crossref_primary_10_1016_j_trsl_2020_11_010
crossref_primary_10_1002_jcb_29542
crossref_primary_10_1016_j_brainresbull_2020_04_017
crossref_primary_10_1016_j_jconrel_2023_04_001
crossref_primary_10_1111_iep_70003
crossref_primary_10_1016_j_biopha_2020_110570
crossref_primary_10_1111_1759_7714_13928
crossref_primary_10_1002_jcb_28611
crossref_primary_10_1016_j_fsi_2018_07_020
crossref_primary_10_1016_j_jbi_2018_11_013
crossref_primary_10_3390_ijms25105507
crossref_primary_10_1002_cbf_3748
crossref_primary_10_1096_fj_202400973RR
crossref_primary_10_1093_bfgp_elad049
crossref_primary_10_1016_j_ijbiomac_2024_130426
crossref_primary_10_2217_rme_2020_0174
crossref_primary_10_1155_2022_9273628
crossref_primary_10_1007_s10142_024_01444_6
crossref_primary_10_3892_or_2021_8137
crossref_primary_10_1093_jb_mvy118
crossref_primary_10_3390_ijms21186658
crossref_primary_10_1016_j_psj_2024_104376
crossref_primary_10_3390_ijms21041193
crossref_primary_10_1002_jcb_28701
crossref_primary_10_1155_2022_5038124
crossref_primary_10_1186_s13045_018_0673_6
crossref_primary_10_3389_fcvm_2023_1155767
crossref_primary_10_3389_fonc_2021_687629
crossref_primary_10_1155_2019_7159592
crossref_primary_10_1007_s12029_021_00744_5
crossref_primary_10_1016_j_prp_2023_154852
crossref_primary_10_3390_cells13110898
crossref_primary_10_1007_s10528_021_10055_w
crossref_primary_10_1128_JVI_00698_21
crossref_primary_10_3390_jcm13103016
crossref_primary_10_1186_s40364_021_00307_7
crossref_primary_10_1016_j_critrevonc_2025_104892
crossref_primary_10_1016_j_drup_2020_100683
crossref_primary_10_1186_s12967_022_03550_0
crossref_primary_10_2174_1574893618666230914160213
crossref_primary_10_1016_j_molimm_2020_10_022
crossref_primary_10_1158_2326_6066_CIR_19_0696
crossref_primary_10_1016_j_prp_2018_12_026
crossref_primary_10_1016_j_bbagrm_2024_195061
crossref_primary_10_1186_s12964_024_01475_3
crossref_primary_10_1039_C8RA05724A
crossref_primary_10_3389_fcimb_2020_00361
crossref_primary_10_3390_biom11081132
crossref_primary_10_1016_j_biopha_2020_110362
crossref_primary_10_1016_j_gene_2018_09_031
crossref_primary_10_1007_s11033_018_4276_7
crossref_primary_10_3389_fimmu_2020_01747
crossref_primary_10_3390_cancers13061274
crossref_primary_10_3389_fonc_2020_614455
crossref_primary_10_3389_fphar_2022_873271
crossref_primary_10_1007_s00284_021_02590_x
crossref_primary_10_1016_j_cellsig_2019_109509
crossref_primary_10_1016_j_psj_2024_103715
crossref_primary_10_1134_S199075082460016X
crossref_primary_10_1016_j_virusres_2020_197907
crossref_primary_10_1016_j_canlet_2022_215763
crossref_primary_10_1016_j_jid_2019_04_021
crossref_primary_10_1016_j_canlet_2022_215645
crossref_primary_10_1016_j_prp_2024_155540
crossref_primary_10_1186_s12920_021_00994_z
crossref_primary_10_3389_fgene_2021_625019
crossref_primary_10_3390_ncrna7020035
crossref_primary_10_1038_s41398_019_0448_z
crossref_primary_10_1016_j_sleep_2023_11_014
crossref_primary_10_1007_s12672_025_02092_3
crossref_primary_10_1007_s00262_021_02937_0
crossref_primary_10_1016_j_biopha_2019_108655
crossref_primary_10_1089_dna_2018_4420
crossref_primary_10_1186_s13578_019_0345_4
crossref_primary_10_1016_j_mce_2020_111064
ContentType Journal Article
DBID NPM
7X8
DOI 10.18632/oncotarget.24307
DatabaseName PubMed
MEDLINE - Academic
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
EISSN 1949-2553
ExternalDocumentID 29719633
Genre Journal Article
Review
GroupedDBID ---
53G
ADBBV
ADRAZ
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
DIK
FRJ
GX1
HYE
KQ8
M48
M~E
NPM
OK1
PGMZT
RPM
7X8
ID FETCH-LOGICAL-c3147-af440ce3a892fa294f021d1c77df4a45ff4262bb14444405fb959261d716b0bd2
IEDL.DBID 7X8
ISSN 1949-2553
IngestDate Thu Jul 10 23:34:51 EDT 2025
Wed Feb 19 02:42:07 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 26
Keywords cancer
long non-coding RNA
CNS disorder
therapy
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3147-af440ce3a892fa294f021d1c77df4a45ff4262bb14444405fb959261d716b0bd2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC5915100
PMID 29719633
PQID 2034293771
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2034293771
pubmed_primary_29719633
PublicationCentury 2000
PublicationDate 2018-Apr-06
PublicationDateYYYYMMDD 2018-04-06
PublicationDate_xml – month: 04
  year: 2018
  text: 2018-Apr-06
  day: 06
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Oncotarget
PublicationTitleAlternate Oncotarget
PublicationYear 2018
References 23776533 - PLoS One. 2013 Jun 11;8(6):e65711
21151960 - PLoS Genet. 2010 Dec 02;6(12):e1001233
2197983 - Annu Rev Biochem. 1990;59:543-68
14527995 - Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12247-52
27666543 - Nat Commun. 2016 Sep 26;7:12791
26975529 - Nat Commun. 2016 Mar 15;7:10982
17553964 - Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10679-84
23756188 - Brain Res Bull. 2013 Aug;97:69-80
27276568 - N Engl J Med. 2016 Jun 9;374(23):2287-9
26816378 - Science. 2016 Jan 15;351(6270):271-5
26142536 - Biochim Biophys Acta. 2016 Jan;1859(1):184-91
25640239 - Cell. 2015 Feb 12;160(4):595-606
23771028 - Hum Mol Genet. 2013 Nov 1;22(21):4318-28
25619660 - Neurobiol Aging. 2015 Mar;36(3):1601.e7-16
16286533 - Obes Res. 2005 Oct;13(10):1841-2
26191476 - Springerplus. 2015 Jul 16;4:349
25419621 - Viruses. 2014 Nov 20;6(11):4505-35
27514530 - J Exp Clin Cancer Res. 2016 Aug 11;35(1):125
27606977 - Pigment Cell Melanoma Res. 2016 Nov;29(6):619-626
17510325 - Science. 2007 Jun 8;316(5830):1484-8
28241429 - Int J Mol Sci. 2017 Feb 22;18(2)
2859520 - Mol Cell Biol. 1985 Mar;5(3):493-500
26977388 - Mol Metab. 2015 Dec 29;5(3):164-70
27694840 - Nat Struct Mol Biol. 2016 Nov;23 (11):1011-1019
29158793 - J Cancer. 2017 Sep 15;8(16):3212-3225
23028363 - PLoS Genet. 2012 Sep;8(9):e1002956
27250026 - Oncotarget. 2016 Jun 28;7(26):40418-40436
28024296 - Nature. 2017 Jan 12;541(7636):228-232
25149110 - J Mol Cell Cardiol. 2014 Nov;76:55-70
24651478 - PLoS Comput Biol. 2014 Mar 20;10(3):e1003517
22081608 - J Biol Chem. 2011 Dec 30;286(52):45093-102
22202438 - Neurobiol Dis. 2012 May;46(2):245-54
26578685 - FASEB J. 2016 Mar;30(3):1187-97
2722860 - J Biol Chem. 1989 Jun 15;264(17):10057-64
3899100 - Biochem J. 1985 Jul 1;229(1):1-17
27618650 - Nat Med. 2016 Oct;22(10 ):1131-1139
24005575 - Hum Genet. 2014 Jan;133(1):59-67
17237763 - Nature. 2007 Feb 8;445(7128):666-70
28542387 - PLoS One. 2017 May 19;12 (5):e0177843
25846769 - Oncol Rep. 2015 Jun;33(6):3045-52
28418892 - Oncotarget. 2017 Jun 13;8(24):39859-39876
27816050 - Aging (Albany NY). 2016 Nov 3;8(11):2948-2960
16915236 - Nature. 2006 Sep 14;443(7108):167-72
23399020 - FEBS J. 2013 Apr;280(7):1709-16
27466303 - Ann Clin Lab Sci. 2016 Jul;46(4):418-24
7589512 - FEBS Lett. 1995 Oct 23;374(1):57-61
21171977 - Orphanet J Rare Dis. 2010 Dec 20;5:40
27362246 - Arch Iran Med. 2016 Jul;19(7):508-17
26586396 - Tumour Biol. 2016 Jan;37(1):163-75
27109570 - Pflugers Arch. 2016 Jun;468(6):1071-87
24890811 - Cancer Sci. 2014 Aug;105(8):951-5
16467349 - Hum Mol Genet. 2006 Mar 15;15(6):965-77
28635106 - CNS Neurosci Ther. 2017 Aug;23 (8):645-656
21785702 - Int J Alzheimers Dis. 2011;2011:929042
23354591 - Cancer Lett. 2013 Jun 10;333(2):213-21
28978995 - Nat Rev Rheumatol. 2017 Nov;13(11):657-669
24115003 - Bioessays. 2013 Dec;35(12):1093-100
27431376 - Oncol Rep. 2016 Sep;36(3):1207-18
22576688 - Int J Oncol. 2012 Jul;41(1):276-84
27618117 - Biomolecules. 2016 Sep 08;6(3)
23835777 - J Cardiovasc Transl Res. 2013 Dec;6(6):876-83
26318290 - Neurobiol Aging. 2015 Nov;36(11):2925-2931
22580042 - Biochim Biophys Acta. 2012 Jul;1823(7):1170-7
28102845 - Cell Death Dis. 2017 Jan 19;8(1):e2569
22996644 - Dis Model Mech. 2013 Mar;6(2):424-33
27659713 - Eur J Med Genet. 2016 Nov;59(11):584-589
23435381 - Nat Struct Mol Biol. 2013 Apr;20(4):440-6
24429688 - Circulation. 2014 Mar 4;129(9):1009-21
15972963 - Am J Pathol. 2005 Jul;167(1):175-91
25123267 - Tumour Biol. 2014 Nov;35(11):11435-42
20541999 - Mol Cell. 2010 Jun 11;38(5):662-74
28611183 - Sci Signal. 2017 Jun 13;10 (483):null
20843979 - Cold Spring Harb Perspect Biol. 2010 Oct;2(10):a003574
18501714 - FEBS Lett. 2008 Jun 11;582(13):1919-27
18957214 - Neuron. 2008 Oct 23;60(2):201-14
24373479 - Eur Urol. 2014 Jun;65(6):1140-51
26633036 - PLoS Genet. 2015 Dec 03;11(12):e1005680
18974356 - Science. 2008 Oct 31;322(5902):750-6
28138111 - Clin Psychopharmacol Neurosci. 2017 Feb 28;15(1):53-58
17604720 - Cell. 2007 Jun 29;129(7):1311-23
24275495 - Nucleic Acids Res. 2014 Jan;42(Database issue):D68-73
26701265 - Genes Dev. 2016 Jan 1;30(1):34-51
20068297 - Cytogenet Genome Res. 2009;126(3):259-70
16914571 - Clin Cancer Res. 2006 Aug 15;12(16):4851-8
27453777 - Transl Neurodegener. 2016 Jul 22;5:14
19182780 - Nature. 2009 Mar 12;458(7235):223-7
28540248 - Transl Androl Urol. 2017 Apr;6(2):326-330
27732939 - Oncotarget. 2017 Jan 17;8(3):5508-5522
11247792 - Am J Physiol Heart Circ Physiol. 2001 Apr;280(4):H1782-92
26138586 - Tumour Biol. 2015 Dec;36(12):9545-52
27546335 - J Neurochem. 2016 Oct;139 Suppl 1:216-231
16537902 - Mol Cell Biol. 2006 Apr;26(7):2560-9
24680897 - Int J Biochem Cell Biol. 2014 Sep;54:318-30
26322075 - Front Genet. 2015 Aug 10;6:263
20368139 - Hum Genomics. 2010 Feb;4(3):170-93
22959273 - Mol Cell. 2012 Oct 26;48(2):219-30
12162957 - J Mol Biol. 2002 Aug 16;321(3):433-45
23160002 - Nat Chem Biol. 2013 Jan;9(1):59-64
25829178 - Nucleic Acids Res. 2015 Apr 30;43(8):4363-4
24495014 - FEBS J. 2014 Apr;281(7):1750-8
17074884 - J Cell Biol. 2006 Nov 6;175(3):427-39
27248326 - Oncotarget. 2016 Jul 12;7(28):43256-43266
26880762 - J Immunol. 2016 Mar 15;196 (6):2799-2808
23064229 - Nature. 2012 Nov 15;491(7424):454-7
25883552 - Front Cell Neurosci. 2015 Apr 01;9:114
27221610 - Mol Neurobiol. 2017 Mar;54(2):1577-1586
27191888 - Oncotarget. 2016 Jun 21;7(25):37957-37965
26621851 - Oncotarget. 2016 Jan 19;7(3):3201-16
8636375 - J Clin Endocrinol Metab. 1996 Apr;81(4):1607-12
20307503 - Brain Res. 2010 Jun 18;1338:36-47
24648007 - Oncol Rep. 2014 May;31(5):1993-2000
24530304 - Mol Cell. 2014 Mar 20;53(6):1005-19
25432725 - Neurol Clin. 2015 Feb;33(1):101-14
21925379 - Mol Cell. 2011 Sep 16;43(6):904-14
12461786 - J Cell Biochem. 2003 Jan 1;88(1):165-80
22266873 - Oncogene. 2012 Oct 25;31(43):4577-87
24667321 - Biochim Biophys Acta. 2014 Oct;1842(10):1910-1922
25777523 - Bioinformatics. 2015 Jul 15;31(14):2241-51
18039709 - Nucleic Acids Res. 2008 Feb;36(2):423-34
24525122 - Biochem Biophys Res Commun. 2014 Mar 7;445(2):388-93
20179156 - Physiol Genomics. 2010 May;41(3):269-74
23102265 - Mol Cell. 2012 Oct 26;48(2):155-7
22955987 - Genome Res. 2012 Sep;22(9):1760-74
28376901 - Radiat Oncol. 2017 Apr 4;12 (1):65
22735187 - EMBO J. 2012 Jun 26;31(14):3038-62
21151178 - Oncogene. 2011 Apr 21;30(16):1956-62
27780933 - Oncotarget. 2016 Nov 15;7(46):74484-74495
21550244 - Trends Cell Biol. 2011 Jun;21(6):354-61
24703882 - Biochim Biophys Acta. 2014 Jul;1843(7):1414-26
15985428 - J Biol Chem. 2005 Aug 19;280(33):29625-36
23697773 - Circ Res. 2013 Jul 19;113(3):266-78
6197186 - Cell. 1983 Dec;35(3 Pt 2):849-57
18045242 - J Neurochem. 2008 Apr;105(2):351-9
8446635 - Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):2092-6
23990798 - PLoS Genet. 2013;9(8):e1003705
27617288 - Sci Adv. 2016 Sep 02;2(9):e1600220
25033876 - BMC Syst Biol. 2014 Jul 17;8:83
25654223 - Int J Mol Sci. 2015 Feb 03;16(2):3251-66
25233276 - Elife. 2014 Sep 16;3:e03523
25560704 - Nat Rev Endocrinol. 2015 Mar;11(3):151-60
25119045 - Nature. 2014 Oct 2;514(7520):102-106
7855987 - Urology. 1995 Feb;45(2):335-8
27586866 - Sci Rep. 2016 Sep 02;6:30798
20956613 - FASEB J. 2011 Feb;25(2):444-8
26788991 - Oncotarget. 2016 Feb 23;7(8):8601-12
22034492 - Circ Res. 2011 Dec 9;109(12):1332-41
22408643 - Front Genet. 2012 Mar 08;3:32
7849716 - Hum Mol Genet. 1994 Oct;3(10):1877-82
28616363 - Curr Pathobiol Rep. 2017 Mar;5(1):23-34
27460088 - Tumour Biol. 2016 Oct;37(10 ):13385-13390
26979073 - Curr Neurovasc Res. 2016;13(2):115-20
18587408 - Nat Med. 2008 Jul;14(7):723-30
20888417 - Neurobiol Dis. 2011 Feb;41(2):308-17
17970741 - Eur J Neurosci. 2007 Nov;26(9):2444-57
28796922 - Cancer Sci. 2017 Nov;108(11):2107-2114
26471251 - Sci Rep. 2015 Oct 16;5:15184
17362513 - BMC Genomics. 2007 Mar 15;8:74
References_xml – reference: 23435381 - Nat Struct Mol Biol. 2013 Apr;20(4):440-6
– reference: 16915236 - Nature. 2006 Sep 14;443(7108):167-72
– reference: 23354591 - Cancer Lett. 2013 Jun 10;333(2):213-21
– reference: 26979073 - Curr Neurovasc Res. 2016;13(2):115-20
– reference: 23990798 - PLoS Genet. 2013;9(8):e1003705
– reference: 28796922 - Cancer Sci. 2017 Nov;108(11):2107-2114
– reference: 26578685 - FASEB J. 2016 Mar;30(3):1187-97
– reference: 27618117 - Biomolecules. 2016 Sep 08;6(3):
– reference: 26142536 - Biochim Biophys Acta. 2016 Jan;1859(1):184-91
– reference: 22959273 - Mol Cell. 2012 Oct 26;48(2):219-30
– reference: 26191476 - Springerplus. 2015 Jul 16;4:349
– reference: 8446635 - Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):2092-6
– reference: 27362246 - Arch Iran Med. 2016 Jul;19(7):508-17
– reference: 14527995 - Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12247-52
– reference: 27191888 - Oncotarget. 2016 Jun 21;7(25):37957-37965
– reference: 20368139 - Hum Genomics. 2010 Feb;4(3):170-93
– reference: 22580042 - Biochim Biophys Acta. 2012 Jul;1823(7):1170-7
– reference: 27431376 - Oncol Rep. 2016 Sep;36(3):1207-18
– reference: 11247792 - Am J Physiol Heart Circ Physiol. 2001 Apr;280(4):H1782-92
– reference: 23399020 - FEBS J. 2013 Apr;280(7):1709-16
– reference: 20307503 - Brain Res. 2010 Jun 18;1338:36-47
– reference: 15972963 - Am J Pathol. 2005 Jul;167(1):175-91
– reference: 23776533 - PLoS One. 2013 Jun 11;8(6):e65711
– reference: 26880762 - J Immunol. 2016 Mar 15;196 (6):2799-2808
– reference: 12162957 - J Mol Biol. 2002 Aug 16;321(3):433-45
– reference: 21785702 - Int J Alzheimers Dis. 2011;2011:929042
– reference: 24680897 - Int J Biochem Cell Biol. 2014 Sep;54:318-30
– reference: 26975529 - Nat Commun. 2016 Mar 15;7:10982
– reference: 17604720 - Cell. 2007 Jun 29;129(7):1311-23
– reference: 18501714 - FEBS Lett. 2008 Jun 11;582(13):1919-27
– reference: 24703882 - Biochim Biophys Acta. 2014 Jul;1843(7):1414-26
– reference: 27694840 - Nat Struct Mol Biol. 2016 Nov;23 (11):1011-1019
– reference: 18039709 - Nucleic Acids Res. 2008 Feb;36(2):423-34
– reference: 25432725 - Neurol Clin. 2015 Feb;33(1):101-14
– reference: 24275495 - Nucleic Acids Res. 2014 Jan;42(Database issue):D68-73
– reference: 17237763 - Nature. 2007 Feb 8;445(7128):666-70
– reference: 27460088 - Tumour Biol. 2016 Oct;37(10 ):13385-13390
– reference: 20541999 - Mol Cell. 2010 Jun 11;38(5):662-74
– reference: 21151178 - Oncogene. 2011 Apr 21;30(16):1956-62
– reference: 24530304 - Mol Cell. 2014 Mar 20;53(6):1005-19
– reference: 26977388 - Mol Metab. 2015 Dec 29;5(3):164-70
– reference: 27276568 - N Engl J Med. 2016 Jun 9;374(23):2287-9
– reference: 22202438 - Neurobiol Dis. 2012 May;46(2):245-54
– reference: 25233276 - Elife. 2014 Sep 16;3:e03523
– reference: 28611183 - Sci Signal. 2017 Jun 13;10 (483):null
– reference: 22735187 - EMBO J. 2012 Jun 26;31(14):3038-62
– reference: 24429688 - Circulation. 2014 Mar 4;129(9):1009-21
– reference: 28138111 - Clin Psychopharmacol Neurosci. 2017 Feb 28;15(1):53-58
– reference: 28241429 - Int J Mol Sci. 2017 Feb 22;18(2):
– reference: 12461786 - J Cell Biochem. 2003 Jan 1;88(1):165-80
– reference: 17362513 - BMC Genomics. 2007 Mar 15;8:74
– reference: 23771028 - Hum Mol Genet. 2013 Nov 1;22(21):4318-28
– reference: 2197983 - Annu Rev Biochem. 1990;59:543-68
– reference: 24373479 - Eur Urol. 2014 Jun;65(6):1140-51
– reference: 16286533 - Obes Res. 2005 Oct;13(10):1841-2
– reference: 25419621 - Viruses. 2014 Nov 20;6(11):4505-35
– reference: 27221610 - Mol Neurobiol. 2017 Mar;54(2):1577-1586
– reference: 28978995 - Nat Rev Rheumatol. 2017 Nov;13(11):657-669
– reference: 27659713 - Eur J Med Genet. 2016 Nov;59(11):584-589
– reference: 20068297 - Cytogenet Genome Res. 2009;126(3):259-70
– reference: 28616363 - Curr Pathobiol Rep. 2017 Mar;5(1):23-34
– reference: 27606977 - Pigment Cell Melanoma Res. 2016 Nov;29(6):619-626
– reference: 23028363 - PLoS Genet. 2012 Sep;8(9):e1002956
– reference: 22576688 - Int J Oncol. 2012 Jul;41(1):276-84
– reference: 22996644 - Dis Model Mech. 2013 Mar;6(2):424-33
– reference: 26586396 - Tumour Biol. 2016 Jan;37(1):163-75
– reference: 27732939 - Oncotarget. 2017 Jan 17;8(3):5508-5522
– reference: 21171977 - Orphanet J Rare Dis. 2010 Dec 20;5:40
– reference: 23835777 - J Cardiovasc Transl Res. 2013 Dec;6(6):876-83
– reference: 24667321 - Biochim Biophys Acta. 2014 Oct;1842(10):1910-1922
– reference: 22081608 - J Biol Chem. 2011 Dec 30;286(52):45093-102
– reference: 26633036 - PLoS Genet. 2015 Dec 03;11(12):e1005680
– reference: 3899100 - Biochem J. 1985 Jul 1;229(1):1-17
– reference: 17970741 - Eur J Neurosci. 2007 Nov;26(9):2444-57
– reference: 25883552 - Front Cell Neurosci. 2015 Apr 01;9:114
– reference: 28102845 - Cell Death Dis. 2017 Jan 19;8(1):e2569
– reference: 26471251 - Sci Rep. 2015 Oct 16;5:15184
– reference: 27453777 - Transl Neurodegener. 2016 Jul 22;5:14
– reference: 24525122 - Biochem Biophys Res Commun. 2014 Mar 7;445(2):388-93
– reference: 2859520 - Mol Cell Biol. 1985 Mar;5(3):493-500
– reference: 19182780 - Nature. 2009 Mar 12;458(7235):223-7
– reference: 22034492 - Circ Res. 2011 Dec 9;109(12):1332-41
– reference: 26138586 - Tumour Biol. 2015 Dec;36(12):9545-52
– reference: 21151960 - PLoS Genet. 2010 Dec 02;6(12):e1001233
– reference: 24648007 - Oncol Rep. 2014 May;31(5):1993-2000
– reference: 16467349 - Hum Mol Genet. 2006 Mar 15;15(6):965-77
– reference: 20956613 - FASEB J. 2011 Feb;25(2):444-8
– reference: 25640239 - Cell. 2015 Feb 12;160(4):595-606
– reference: 26788991 - Oncotarget. 2016 Feb 23;7(8):8601-12
– reference: 27250026 - Oncotarget. 2016 Jun 28;7(26):40418-40436
– reference: 18974356 - Science. 2008 Oct 31;322(5902):750-6
– reference: 6197186 - Cell. 1983 Dec;35(3 Pt 2):849-57
– reference: 24890811 - Cancer Sci. 2014 Aug;105(8):951-5
– reference: 2722860 - J Biol Chem. 1989 Jun 15;264(17):10057-64
– reference: 25846769 - Oncol Rep. 2015 Jun;33(6):3045-52
– reference: 7589512 - FEBS Lett. 1995 Oct 23;374(1):57-61
– reference: 25119045 - Nature. 2014 Oct 2;514(7520):102-106
– reference: 24115003 - Bioessays. 2013 Dec;35(12):1093-100
– reference: 27617288 - Sci Adv. 2016 Sep 02;2(9):e1600220
– reference: 26322075 - Front Genet. 2015 Aug 10;6:263
– reference: 18045242 - J Neurochem. 2008 Apr;105(2):351-9
– reference: 28635106 - CNS Neurosci Ther. 2017 Aug;23 (8):645-656
– reference: 27466303 - Ann Clin Lab Sci. 2016 Jul;46(4):418-24
– reference: 18587408 - Nat Med. 2008 Jul;14(7):723-30
– reference: 29158793 - J Cancer. 2017 Sep 15;8(16):3212-3225
– reference: 20888417 - Neurobiol Dis. 2011 Feb;41(2):308-17
– reference: 27109570 - Pflugers Arch. 2016 Jun;468(6):1071-87
– reference: 17510325 - Science. 2007 Jun 8;316(5830):1484-8
– reference: 7855987 - Urology. 1995 Feb;45(2):335-8
– reference: 26816378 - Science. 2016 Jan 15;351(6270):271-5
– reference: 20843979 - Cold Spring Harb Perspect Biol. 2010 Oct;2(10):a003574
– reference: 25123267 - Tumour Biol. 2014 Nov;35(11):11435-42
– reference: 15985428 - J Biol Chem. 2005 Aug 19;280(33):29625-36
– reference: 23697773 - Circ Res. 2013 Jul 19;113(3):266-78
– reference: 22266873 - Oncogene. 2012 Oct 25;31(43):4577-87
– reference: 25560704 - Nat Rev Endocrinol. 2015 Mar;11(3):151-60
– reference: 17074884 - J Cell Biol. 2006 Nov 6;175(3):427-39
– reference: 27514530 - J Exp Clin Cancer Res. 2016 Aug 11;35(1):125
– reference: 25033876 - BMC Syst Biol. 2014 Jul 17;8:83
– reference: 28418892 - Oncotarget. 2017 Jun 13;8(24):39859-39876
– reference: 16914571 - Clin Cancer Res. 2006 Aug 15;12(16):4851-8
– reference: 24005575 - Hum Genet. 2014 Jan;133(1):59-67
– reference: 26701265 - Genes Dev. 2016 Jan 1;30(1):34-51
– reference: 24495014 - FEBS J. 2014 Apr;281(7):1750-8
– reference: 25149110 - J Mol Cell Cardiol. 2014 Nov;76:55-70
– reference: 23102265 - Mol Cell. 2012 Oct 26;48(2):155-7
– reference: 7849716 - Hum Mol Genet. 1994 Oct;3(10):1877-82
– reference: 8636375 - J Clin Endocrinol Metab. 1996 Apr;81(4):1607-12
– reference: 24651478 - PLoS Comput Biol. 2014 Mar 20;10(3):e1003517
– reference: 27816050 - Aging (Albany NY). 2016 Nov 3;8(11):2948-2960
– reference: 18957214 - Neuron. 2008 Oct 23;60(2):201-14
– reference: 28540248 - Transl Androl Urol. 2017 Apr;6(2):326-330
– reference: 27586866 - Sci Rep. 2016 Sep 02;6:30798
– reference: 27546335 - J Neurochem. 2016 Oct;139 Suppl 1:216-231
– reference: 23064229 - Nature. 2012 Nov 15;491(7424):454-7
– reference: 23160002 - Nat Chem Biol. 2013 Jan;9(1):59-64
– reference: 27780933 - Oncotarget. 2016 Nov 15;7(46):74484-74495
– reference: 21925379 - Mol Cell. 2011 Sep 16;43(6):904-14
– reference: 21550244 - Trends Cell Biol. 2011 Jun;21(6):354-61
– reference: 26621851 - Oncotarget. 2016 Jan 19;7(3):3201-16
– reference: 20179156 - Physiol Genomics. 2010 May;41(3):269-74
– reference: 27248326 - Oncotarget. 2016 Jul 12;7(28):43256-43266
– reference: 16537902 - Mol Cell Biol. 2006 Apr;26(7):2560-9
– reference: 25829178 - Nucleic Acids Res. 2015 Apr 30;43(8):4363-4
– reference: 26318290 - Neurobiol Aging. 2015 Nov;36(11):2925-2931
– reference: 25619660 - Neurobiol Aging. 2015 Mar;36(3):1601.e7-16
– reference: 28024296 - Nature. 2017 Jan 12;541(7636):228-232
– reference: 28376901 - Radiat Oncol. 2017 Apr 4;12 (1):65
– reference: 22408643 - Front Genet. 2012 Mar 08;3:32
– reference: 17553964 - Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10679-84
– reference: 25777523 - Bioinformatics. 2015 Jul 15;31(14):2241-51
– reference: 22955987 - Genome Res. 2012 Sep;22(9):1760-74
– reference: 27666543 - Nat Commun. 2016 Sep 26;7:12791
– reference: 23756188 - Brain Res Bull. 2013 Aug;97:69-80
– reference: 28542387 - PLoS One. 2017 May 19;12 (5):e0177843
– reference: 25654223 - Int J Mol Sci. 2015 Feb 03;16(2):3251-66
– reference: 27618650 - Nat Med. 2016 Oct;22(10 ):1131-1139
SSID ssj0000547829
Score 2.5557802
SecondaryResourceType review_article
Snippet LncRNAs are long non-coding regulatory RNAs that are longer than 200 nucleotides. One of the major functions of lncRNAs is the regulation of specific gene...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 18648
Title Molecular mechanisms of long noncoding RNAs and their role in disease pathogenesis
URI https://www.ncbi.nlm.nih.gov/pubmed/29719633
https://www.proquest.com/docview/2034293771
Volume 9
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEA7qevDiA1_riwheo22SbZKTLOLiZcuyKOyt5NEsBW1Xq_5-J9mungTBHnIrDMNkZr6ZyXwIXXHlfJYJRyylinBHPVGGM2JcQo3NjNPOR7IJkedyNlOTruDWdmOVK58YHbVrbKiRA0hn4DqZEOnt4pUE1qjQXe0oNNZRj0EqE6xazOR3jSUJy6oiURlAdUUge2ZdY1NmjN40Yf1BnLe-ppwl4vckMwab0c5_xdxF212aiYdLu9hDa2W9j6bjFRcufinDi9-qfWlx4_FzU89xHQQNkQxP82GLde1w7CLgMICIqxp3vRwcSIybefCRVXuAnkb3j3cPpONUIJalXBDtOU9sybRU1GuquIcg71IrhPNc84H3YUW9MYCz4EsG3qiBApTlAFeZxDh6iDZAnvIYYWFsopW0EiAWtzyR2lKvWCZTYaQzaR9drlRUgM2GRoSuy-ajLX6U1EdHSz0Xi-VyjYIqEZwCO_nD36doC_IXGQdpsjPU83Bjy3O0aT_fq_btIhoDnPlk_AVXb7_o
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Molecular+mechanisms+of+long+noncoding+RNAs+and+their+role+in+disease+pathogenesis&rft.jtitle=Oncotarget&rft.au=Hu%2C+Guoku&rft.au=Niu%2C+Fang&rft.au=Humburg%2C+Bree+A&rft.au=Liao%2C+Ke&rft.date=2018-04-06&rft.eissn=1949-2553&rft.volume=9&rft.issue=26&rft.spage=18648&rft_id=info:doi/10.18632%2Foncotarget.24307&rft_id=info%3Apmid%2F29719633&rft_id=info%3Apmid%2F29719633&rft.externalDocID=29719633
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1949-2553&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1949-2553&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1949-2553&client=summon